Products for Research Use Only

Factor Xa Chromogenic Substrate

CAT: 0952-B2012709Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0952-B2012709Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Factor Xa Chromogenic Substrate_x000D_ Catalog number: B2012709_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 5 mg_x000D_ Molecular Weight or Concentration: N/A_x000D_ Supplied as: Lyophilized Powder_x000D_ Applications: molecular tool for various biochemical applications_x000D_ Storage: 2-8°C_x000D_ Keywords: CH3OCO-D-CHA-Gly-Arg-pNA-AcOH_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Yuri M, Tabe Y, Tsuchiya K, Sadatsuki R, Aoki J, Horii T, Iba T, Ohsaka A. Evaluation of Factor Xa-Specific Chromogenic Substrate Assays and the Determination of Pharmacokinetics of Fondaparinux Clin Appl Thromb Hemost. 2016 Jul;22(5):453-8._x000D_ 2: Rosen S, Tiefenbacher S, Robinson M, Huang M, Srimani J, Mackenzie D, Christianson T, Pasi KJ, Rangarajan S, Symington E, Giermasz A, Pierce GF, Kim B, Zoog SJ, Vettermann C. Activity of transgene-produced B-domain-deleted factor VIII in human plasma following AAV5 gene therapy Blood. 2020 Nov 26;136(22):2524-2534._x000D_ 3: Drozd NN, Kuznetsova SA, Malyar YN, Kazachenko AS, Borovkova VS, Berezhnaya YD. Thrombin and Factor Xa Hydrolysis of Chromogenic Substrates in the Presence of Sulfated Derivatives of Galactomannan and Galactoglucomannan Natural Gels Pharmaceutics. 2022 Dec 1;14(12):2678._x000D_ 4: Lollar P, Knutson GJ, Fass DN. Activation of porcine factor VIII:C by thrombin and factor Xa Biochemistry. 1985 Dec 31;24(27):8056-64._x000D_ 5: Harenberg J, Krämer R, Giese C, Marx S, Weiss C, Wehling M. Determination of rivaroxaban by different factor Xa specific chromogenic substrate assays: reduction of interassay variability J Thromb Thrombolysis. 2011 Oct;32(3):267-71._x000D_ 6: Bohling SD, Pagano MB, Stitzel MR, Ferrell C, Yeung W, Chandler WL. comparison of clot-based vs chromogenic factor Xa procoagulant phospholipid activity assays Am J Clin Pathol. 2012 Feb;137(2):185-92._x000D_ 7: Madaras F, Chew MY, Parkin JD. Automated estimation of factor Xa using the chromogenic substrate S-2222 Haemostasis. 1981;10(5):271-5._x000D_ 8: Nishibe H. The assay of factor V in plasma using a synthetic chromogenic substrate Clin Chim Acta. 1980 Oct 9;106(3):301-7._x000D_ 9: Bardy G, Fischer F, Appert A, Baldin B, Stève M, Spreux A, Lavrut T, Drici MD. Is anti-factor Xa chromogenic assay for Rivaroxaban appropriate in clinical practice? Advantages and comparative drawbacks Thromb Res. 2015 Aug;136(2):396-401._x000D_ 10: Bendz B, Andersen TO, Sandset PM. A new sensitive chromogenic substrate assay of tissue factor pathway inhibitor type 1 Thromb Res. 2000 Mar 15;97(6):463-72. _x000D_ _x000D_ Products Related to Factor Xa Chromogenic Substrate can be found at Substrates
Short Description
Catalog Number: B2012709 (5 mg)
Weight
0.15
Length
2
Width
0.5
Height
0.5